ADHD Trial, Recruiting NCT07147894 Sponsor: Northeastern University Condition: ADHD
Back to Adhd

ADHD Trial, Recruiting

NCT07147894
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Children aged 12 to 17 years old.
  • The child must have a parent or guardian who is available to take part in the trial as a helper during training.
  • Both the child and their parent or guardian must be able to understand and speak enough English or Spanish to take part in the study activities.
  • Both the child and their parent or guardian must be willing to agree to take part, be assigned to either study group by chance, and follow the study plan they are given.
  • Around half of the children enrolled will need to have a formal diagnosis of ADHD based on current diagnostic guidelines (DSM-5).

Who may not be able to join:

  • Children who are currently taking ADHD medication or stimulant medication.
  • Children who have been formally identified as having an intellectual disability.
  • Children who have vision or hearing difficulties that would make it too hard to take part in the study activities or assessments.
  • Children with a history of certain brain-related conditions (such as those caused by brain injury or neurodegenerative disease), psychosis, autism spectrum disorder, intellectual disability, or who are currently experiencing substance use issues or thoughts of suicide. Children in this situation would be directed to psychiatric support services.
  • Children with significant physical or sensory difficulties that would prevent valid cognitive testing from being carried out.
  • Children with colour blindness who are unable to tell apart the colours used in the study tasks.
  • Children who are considered a vulnerable population, such as those in the care of the state (wards), or those with neurological or other health conditions that may affect the ability to give informed consent.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Aaron Seitz, PhD, Northeastern University

Phone: (626) 482-8091

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Northeastern University
Registry
ClinicalTrials.gov
Start date
14 December 2025
Est. completion
30 June 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Adherence Composite; Working Memory Composite; Inhibition/Flexibility Composite

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov